Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STI571 in CML Blast Crisis
NCT00006475Phase 2Completed
- Sponsor
- Novartis
- Start
- Sep 2000
- Primary completion
- Dec 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in chronic myeloid leukemia blast crisis (CML-BC), sponsored by Novartis. Started Sep 2000; status: completed.
02
Drugs
03
Conditions
chronic myeloid leukemia blast crisis (CML-BC)
Beyond the preview
Go deeper on NCT00006475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006475.